BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...

BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....

BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to...

BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids FREDERICK, MD, Dec. 12, 2017 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device, ActiPatch, announced today the...

BioElectronics Announces the Launch of the ‘Try & Tell’ Program FREDERICK, MD, Dec. 07, 2017 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device ActiPatch, announced today the...